Baker Avenue Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Baker Avenue Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Buy	22,813 +13,930	+157%	+$812K	0.03%	248
2025 Q4	$479K	Buy	8,883 +147	+2%	+$7.07K	0.01%	391
2025 Q3	$394K	Buy	8,736 +3,984	+84%	+$186K	0.01%	408
2025 Q2	$220K	Buy	4,752 +1,232	+35%	+$60.5K	0.01%	451
2025 Q1	$215K	Sell	3,520 -432	-11%	-$25.2K	0.01%	426
2024 Q4	$224K	Buy	+3,952	New	+$221K	0.01%	389
2023 Q4	–	Sell	-1,441	Closed	-$83.6K	–	516
2023 Q3	$83.6K	Sell	1,441 -174	-11%	-$10.7K	﹤0.01%	448
2023 Q2	$103K	Buy	1,615 +482	+43%	+$32.3K	0.01%	426
2023 Q1	$78.5K	Buy	1,133 +178	+19%	+$12.6K	﹤0.01%	467
2022 Q4	$68.7K	Buy	+955	New	+$72K	﹤0.01%	453
2022 Q3	–	Sell	-11,378	Closed	-$876K	–	337
2022 Q2	$876K	Buy	11,378 +4,235	+59%	+$323K	0.06%	164
2022 Q1	$522K	Buy	+7,143	New	+$480K	0.03%	213
2015 Q4	–	Sell	-4,156	Closed	-$246K	–	183
2015 Q3	$246K	Sell	4,156 -101	-2%	-$6.41K	0.04%	168
2015 Q2	$283K	Buy	4,257 +301	+8%	+$19.8K	0.04%	204
2015 Q1	$255K	Hold	3,956	–	–	0.03%	199
2014 Q4	$234K	Hold	3,956	–	–	0.03%	235
2014 Q3	$202K	Buy	+3,956	New	+$198K	0.03%	246

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baker Avenue Asset Management's BMY Position: Q1 2026 in Review

Baker Avenue Asset Management increased its Bristol-Myers Squibb (BMY) stake by 157% in Q1 2026, buying an estimated $812K and bringing the position to 22,813 shares worth $1.38M. The position accounts for 0.03% of the portfolio, ranked #248.

Baker Avenue Asset Management first reported a position in BMY in Q3 2014 and has held it in 17 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Baker Avenue Asset Management held 22,813 shares of Bristol-Myers Squibb worth $1.38M as of Q1 2026.
Baker Avenue Asset Management bought 13,930 Bristol-Myers Squibb shares in Q1 2026, an estimated $812K.
Bristol-Myers Squibb made up 0.03% of Baker Avenue Asset Management's portfolio in Q1 2026, its #248 holding.
Baker Avenue Asset Management first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 17 quarters since.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Baker Avenue Asset Management's 13F filing for Q1 2026, filed 12 May 2026.